Vanguard FTSE Developed Europe ex UK UCITS ETF Accuimulation (GBP) | VERGRegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 2,5 | 23,9 | -12,1 | 18,4 | 5,4 | |
+/-Kat | -0,6 | 0,9 | 1,6 | 1,8 | -0,8 | |
+/-Indeks | 0,8 | -1,0 | 0,4 | 0,3 | -1,0 | |
Kategori: Aktier - Europa ex. England | ||||||
Kategoribenchmark: Morningstar DM Eur xUK TME ... |
Oversigt | ||
Closing Price 16-05-2024 | GBX 4004,75 | |
Kursændring 1 dag | -0,26% | |
Morningstar Kategori™ | Aktier - Europa ex. England | |
Omsætning | 29629 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BK5BQY34 | |
Markedsværdi i alt (mio.) 16-05-2024 | EUR 2688,42 | |
Seneste TNA(mio.) 16-05-2024 | EUR 507,40 | |
Løbende omkostning 01-03-2024 | 0,10% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Vanguard FTSE Developed Europe ex UK UCITS ETF Accuimulation (GBP) | VERG |
This Fund seeks to track the performance of the Index, a widely recognised market- capitalization weighted index of stock market performance of European developed countries, excluding the United Kingdom, that is comprised of the stocks of large and mid capitalisation companies in that region. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Ikke oplyst af foreningen 30-09-2014 | ||
Startdato 23-07-2019 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
FTSE Developed Europe ex UK NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Formuefordeling Vanguard FTSE Developed Europe ex UK UCITS ETF Accuimulation (GBP) | VERG | 30-04-2024 |
|
|
Top 5 placeringer | Sektor | % |
Novo Nordisk A/S Class B | Healthcare | 4,77 |
ASML Holding NV | Teknologi | 4,18 |
Nestle SA | Forbrugsvarer | 3,20 |
Lvmh Moet Hennessy Louis Vuitton SE | Cyklisk forbrug | 2,44 |
Novartis AG Registered Shares | Healthcare | 2,39 |
Øget Mindsket Ny siden sidste portefølje | ||
Vanguard FTSE Developed Europe ex UK UCITS ETF Accuimulation (GBP) | VERG |